CJ CheilJedang Responds to Bio Division Sale Reports: "Reviewing Various Strategic Options"

CJ CheilJedang announced on the 19th that it is "reviewing various strategic options" regarding reports of the sale of its bio business division, and that "no decisions have been made yet."

In response to an inquiry disclosure request about the report, CJ CheilJedang stated, "We are reviewing various strategic options for the bio business, but no specific decisions have been made so far."

They added, "We will re-disclose the information when specific details are decided or within one month." The scheduled date for the re-disclosure is the 18th of next month.